|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.230 CAD | -1.86% |
|
+0.71% | -12.24% |
| 06-26 | HLS Therapeutics Inc. - Shareholder/Analyst Call | |
| 06-23 | HLS Therapeutics to Begin its Normal Course Issuer Bid | MT |
| Market Cap | 93.57M 82.21M 76.23M 70.1M 132M 8.95B 135M 909M 356M 4.4B 351M 344M 15.2B | P/E 2026 * |
-15x | P/E 2027 * | -99.7x |
|---|---|---|---|---|---|
| Enterprise Value | 93.57M 82.21M 76.23M 70.1M 132M 8.95B 135M 909M 356M 4.4B 351M 344M 15.2B | EV / Sales 2026 * |
1.61x | EV / Sales 2027 * | 1.45x |
| Free-Float |
99.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HLS Therapeutics Inc.
| 1 day | -1.86% | ||
| 1 week | +0.71% | ||
| Current month | -4.08% | ||
| 1 month | -2.98% | ||
| 3 months | -7.03% | ||
| 6 months | -10.00% | ||
| Current year | -12.24% |
| 1 week | 4.2 |  | 4.39 |
| 1 month | 4 | | 5.25 |
| Current year | 4 | | 5.25 |
| 1 year | 4 | | 5.76 |
| 3 years | 3 | | 7.12 |
| 5 years | 3 | | 20.52 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 01/05/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 26/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 12/03/2018 |
John Welborn
CHM | Chairman | 48 | 22/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-17 | Buy | Chief Executive Officer | 2,000 | 0.0064% | ||
| 06-16 | Buy | Chief Financial Officer | 4,000 | 0.0128% | ||
| 04-02 | Option | Chairman | 13,120 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.86% | +0.71% | -12.96% | -36.58% | 95.33M | |
| +0.78% | +3.30% | +14.47% | +98.71% | 94.36B | |
| -0.91% | -2.21% | +45.16% | +149.72% | 55.23B | |
| +3.55% | +4.66% | +2.10% | +269.62% | 22.56B | |
| +1.24% | +1.30% | -14.05% | -22.35% | 8.01B | |
| -0.75% | -2.96% | -27.34% | -35.23% | 7.6B | |
| +0.72% | +0.66% | -10.56% | -27.84% | 6.66B | |
| -1.55% | -3.01% | +20.10% | +33.78% | 6.25B | |
| +0.81% | +1.22% | -0.23% | +23.95% | 5.36B | |
| +1.00% | +2.43% | -5.24% | -6.08% | 3.68B | |
| Average | +0.30% | +0.68% | +1.14% | +44.77% | 20.98B | |
| Weighted average by Cap. | +0.53% | +0.93% | +17.25% | +111.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.03M 50.98M 47.27M 43.47M 82.12M 5.55B 83.9M 564M 221M 2.73B 218M 213M 9.42B | 64.31M 56.5M 52.39M 48.18M 91.01M 6.15B 92.98M 625M 245M 3.02B 241M 236M 10.44B |
| Net income | -6.26M -5.5M -5.1M -4.69M -8.87M -599M -9.06M -60.84M -23.82M -294M -23.52M -23.01M -1.02B | -1.05M -923K -855K -787K -1.49M -100M -1.52M -10.2M -3.99M -49.34M -3.94M -3.86M -171M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | CA$4.230 | -1.86% | 2,300 |
| 10/07/26 | CA$4.310 | +0.70% | 30,010 |
| 09/07/26 | CA$4.280 | -0.23% | 8,400 |
| 08/07/26 | CA$4.290 | -0.23% | 6,361 |
| 07/07/26 | CA$4.300 | 0.00% | 4,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
